Chen Schor

Chen Schor was the founder of resTORbio, Inc., founded in 2016, serving as President, CEO, CFO, Secretary & Director in 2020.
Current jobs include President, Chief Executive Officer & Director at Adicet Bio, Inc. since 2016; Chairman at Carbon Biosciences, Inc.; Director at Otic Pharma Ltd.; Director at Alliance for Cancer Gene Therapy, Inc.; and Independent Director at Karyopharm Therapeutics, Inc. since 2020.
Former jobs include President, Chief Executive Officer & Director at Synta Pharmaceuticals Corp.
from 2015 to 2016; President, Chief Executive Officer & Director at Novalere, Inc.; President, Chief Executive Officer & Director at Adicet Therapeutics, Inc.; Director at Brainstorm Cell Therapeutics, Inc. from 2011 to 2020; Director at Gelesis, Inc.; Director at Cerapedics, Inc.; Director at Quiet Therapeutics Ltd.; Vice President-Business Development at Teva Pharmaceutical Industries Ltd. from 2009 to 2011; Chief Business Officer at EPIX Pharmaceuticals, Inc. from 2003 to 2009; Chief Business Officer at Predix Pharmaceuticals, Inc. from 2003 to 2009; VP-Business Development, Global Branded Products at Teva Pharmaceuticals USA, Inc. from 2009 to 2011; Partner at XT Hi-Tech Investments (1992) Ltd. from 1998 to 2003; Principal at Arthur Anderson & Co.; Chief Business Officer at Sesen Bio, Inc. from 2011 to 2012; and Partner at Yozma Venture Capital Ltd. Education includes undergraduate and MBA degrees from Tel-Aviv University and an undergraduate degree from the University of Haifa.